Abbott's Xience Prime nets FDA clearance
Abbott has received FDA approval for the next-generation Xience Prime everolimus-eluting coronary stent system for the treatment of coronary artery disease. Xience Prime uses the same drug and biocompatible polymer as the Xience V everolimus-eluting ...
FDA Approves Abbott's Xience Prime Drug-Eluting Stent
Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug ...
FDA Approves Xience Prime Stent